Search details
1.
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study.
Diabetes Obes Metab
; 22(11): 2004-2012, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32729217
2.
A post-hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus 100 U/mL (Gla-100) over wider nocturnal windows in individuals with type 2 diabetes on a basal-only insulin regimen.
Diabetes Obes Metab
; 21(2): 402-407, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30160030
3.
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting.
Diabetes Obes Metab
; 21(6): 1429-1436, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30768845
4.
Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).
Diabetes Obes Metab
; 20(2): 448-452, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28736942
5.
Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment.
Diabetes Obes Metab
; 20(12): 2860-2868, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30003642
6.
Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?
Hepatology
; 49(6): 1896-903, 2009 Jun.
Article
in English
| MEDLINE | ID: mdl-19434725
7.
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes.
Diabetes Ther
; 11(6): 1293-1302, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32304086
8.
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus.
Curr Med Res Opin
; 36(4): 571-581, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31865758
9.
Ectopic fat deposition and the metabolic syndrome in obese children and adolescents.
Horm Res
; 71 Suppl 1: 2-7, 2009 Jan.
Article
in English
| MEDLINE | ID: mdl-19153496
10.
Obesity in children and adolescents.
J Clin Endocrinol Metab
; 93(11 Suppl 1): S31-6, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-18987268
11.
Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents.
J Clin Endocrinol Metab
; 93(5): 1767-73, 2008 May.
Article
in English
| MEDLINE | ID: mdl-18303080
12.
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.
Diabetes Care
; 41(10): 2147-2154, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30104294
13.
Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial.
JAMA
; 297(24): 2697-704, 2007 Jun 27.
Article
in English
| MEDLINE | ID: mdl-17595270
14.
Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome.
J Clin Endocrinol Metab
; 91(11): 4415-23, 2006 Nov.
Article
in English
| MEDLINE | ID: mdl-16926246
15.
Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes.
Postgrad Med
; 128(8): 731-739, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27690710
16.
Rare variants in single-minded 1 (SIM1) are associated with severe obesity.
J Clin Invest
; 123(7): 3042-50, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23778139
17.
Rosiglitazone improves glucose metabolism in obese adolescents with impaired glucose tolerance: a pilot study.
Obesity (Silver Spring)
; 19(1): 94-9, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20467418
18.
Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.
Diabetes Care
; 33(8): 1817-22, 2010 Aug.
Article
in English
| MEDLINE | ID: mdl-20668154
19.
Downregulation of ADIPOQ and PPARγ2 gene expression in subcutaneous adipose tissue of obese adolescents with hepatic steatosis.
Obesity (Silver Spring)
; 18(10): 1911-7, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-20168312
20.
Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis.
Diabetes
; 59(9): 2288-96, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20805387